{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:55:42Z","timestamp":1788850542244,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.08.069","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T11:46:28Z","timestamp":1536666388000},"page":"6253-6261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence"],"prefix":"10.1016","volume":"36","author":[{"given":"Claire","family":"Dendle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda L.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Mulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2018.08.069_b0005","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1111\/j.1600-6143.2009.02917.x","article-title":"Guidelines for vaccination of SOT candidates and recipients","volume":"9","author":"Danzinger-Isakov","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2018.08.069_b0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1378\/chest.130.1.218","article-title":"Low prevalence of prior Streptococcus pneumoniae vaccination among potential lung transplant candidates","volume":"130","author":"Gasink","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2018.08.069_b0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jinf.2015.07.004","article-title":"Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed","volume":"71","author":"Sangil","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.08.069_b0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.12659\/AOT.896436","article-title":"Vaccination status of pneumococcal and other vaccines in 444 liver transplant patients compared to a representative population sample","volume":"21","author":"Weltermann","year":"2016","journal-title":"Ann Transplant"},{"key":"10.1016\/j.vaccine.2018.08.069_b0030","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/374784","article-title":"Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients","volume":"187","author":"Kumar","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1600-6143.2006.01705.x","article-title":"Invasive pneumococcal disease in SOT recipients\u201310-year prospective population surveillance","volume":"7","author":"Kumar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2018.08.069_b0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/civ803","article-title":"Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs","volume":"62","author":"Shigayeva","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0045","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.08.069_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.08.069_b0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00007890-199001000-00027","article-title":"Increased risk of pneumococcal infections in cardiac transplant recipients","volume":"49","author":"Amber","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2018.08.069_b0060","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/cid\/cit640","article-title":"Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies","volume":"57","author":"Luj\u00e1n","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen","volume":"42","author":"Sj\u00f6str\u00f6m","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/thx.2009.123612","article-title":"Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes","volume":"65","author":"Garcia-Vidal","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2018.08.069_b0075","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1128\/IAI.00724-13","article-title":"Surface charge of Streptococcus pneumoniae predicts serotype distribution","volume":"81","author":"Li","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.08.069_b0080","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1016\/j.vaccine.2010.04.103","article-title":"The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly","volume":"28","author":"Baxendale","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.069_b0085","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00006454-200004000-00035","article-title":"Immunogenicity of pneumococcal conjugate vaccines","volume":"19","author":"Eskola","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.08.069_b0095","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus-dependent responses to polysaccharide antigens","volume":"165","author":"Stein","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1600-6143.2007.01668.x","article-title":"Immunogenicity of pneumococcal vaccine in renal transplant recipients\u2013three year follow-up of a randomized trial","volume":"7","author":"Kumar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2018.08.069_b0105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0110","first-page":"93","article-title":"Vaccine against pneumococcal pneumonia in adults","volume":"373","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000658-198008000-00012","article-title":"Response of renal allograft recipients to pneumococcal vaccine","volume":"192","author":"Silberman","year":"1980","journal-title":"Ann Surg"},{"key":"10.1016\/j.vaccine.2018.08.069_b0120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1981.128","article-title":"Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients","volume":"20","author":"Cosio","year":"1981","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2018.08.069_b0125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3181\/00379727-182-42367","article-title":"Pneumococcal vaccine immunization of patients with renal impairment","volume":"182","author":"Rytel","year":"1986","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0130","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.1981.00340130081018","article-title":"Response to pneumococcal vaccine in renal transplant and hemodialysis patients","volume":"141","author":"Linnemann","year":"1981","journal-title":"Arch Int Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0135","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archinte.1986.00360200116019","article-title":"Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine","volume":"146","author":"Linnemann","year":"1986","journal-title":"Arch Int Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000166899","article-title":"Response to pneumococcal vaccine in renal allograft recipients","volume":"5","author":"Arnold","year":"1985","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.vaccine.2018.08.069_b0145","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1055\/s-2008-1043177","article-title":"Pneumococcal vaccination after heart and liver transplantation. Immune responses in immunosuppressed patients and in healthy controls","volume":"121","author":"Dengler","year":"1996","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.vaccine.2018.08.069_b0150","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/00007890-199811270-00014","article-title":"Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation","volume":"66","author":"Dengler","year":"1998","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.vaccine.2018.08.069_b0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1399-0012.2000.140111.x","article-title":"Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine","volume":"14","author":"Kazancio\u011flu","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.vaccine.2018.08.069_b0160","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/315245","article-title":"Pneumococcal vaccine response in cirrhosis and liver transplantation","volume":"181","author":"McCashland","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/318482","article-title":"Immunogenicity of pneumococcal vaccine in heart transplant recipients","volume":"32","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0170","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.intimp.2006.09.011","article-title":"Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation","volume":"6","author":"Sarmiento","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.08.069_b0175","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1600-6143.2007.01869.x","article-title":"The effect of sirolimus therapy on vaccine responses in transplant recipients","volume":"7","author":"Willcocks","year":"2007","journal-title":"Am J Transplant. Blackwell Publishing Ltd"},{"key":"10.1016\/j.vaccine.2018.08.069_b0180","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1086\/591537","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients","volume":"47","author":"Kumar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0185","first-page":"43","article-title":"Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: a comparative controlled trial","volume":"13","author":"Pourfarziani","year":"2008","journal-title":"Ann Transplant"},{"issue":"12","key":"10.1016\/j.vaccine.2018.08.069_b0190","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/TP.0b013e3181f5d878","article-title":"Immunity to pneumococcal antigens in kidney transplant recipients","volume":"90","author":"Lindemann","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2018.08.069_b0195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1399-3062.2011.00628.x","article-title":"Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants","volume":"13","author":"Gattringer","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.08.069_b0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/TP.0b013e318250fc8c","article-title":"Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients","volume":"94","author":"Lindemann","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2018.08.069_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046133","article-title":"Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients","volume":"7","author":"Tobudic","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.08.069_b0210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/tri.12959","article-title":"Discrepant serological assays for Pneumococcus in renal transplant recipients \u2013 a prospective study","volume":"30","author":"Fishman","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.vaccine.2018.08.069_b0215","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.vaccine.2009.11.011","article-title":"Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance","volume":"28","author":"Balloch","year":"2010","journal-title":"Vaccine"},{"issue":"1772\u20131779","key":"10.1016\/j.vaccine.2018.08.069_b0220","article-title":"No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine","volume":"137","author":"Licciardi","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.08.069_b0225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.08.069_b0230","first-page":"1019","article-title":"Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae","volume":"10","author":"Romero-Steiner","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.08.069_b0235","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.08.069_b0240","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1081-1206(10)60572-8","article-title":"Assessment and clinical interpretation of polysaccharide antibody responses","volume":"99","author":"Paris","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2018.08.069_b0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(98)70089-2","article-title":"Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations","volume":"102","author":"Sorensen","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2018.08.069_b0250","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1093\/clinids\/3.Supplement_1.S184","article-title":"Assessment of the antibody response to pneumococcal vaccine in high-risk populations","volume":"3","author":"Landesman","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0255","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O'Brien","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.08.069_b0265","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0270","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1016\/j.vaccine.2009.06.098","article-title":"Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine","volume":"27","author":"Russell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.069_b0275","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2006.09.036","article-title":"Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children","volume":"118","author":"Kamchaisatian","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.08.069_b0280","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.069_b0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ebm.14.4.109","article-title":"Review: pneumococcal vaccination is not effective for preventing pneumonia, bacteraemia, bronchitis, or mortality","volume":"14","author":"Johnstone","year":"2009","journal-title":"Evid Based Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0290","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-150-10-200905190-02004","article-title":"Review: pneumococcal vaccination is not effective for preventing pneumonia, bacteremia, bronchitis, or mortality","volume":"150","author":"Johnstone","year":"2009","journal-title":"Ann Int Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0295","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2018.08.069_b0300","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1001\/archinte.167.18.1938","article-title":"Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia","volume":"167","author":"Johnstone","year":"2007","journal-title":"Arch Int Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0305","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"French","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.08.069_b0310","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1001\/archinte.160.17.2633","article-title":"Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients","volume":"160","author":"Breiman","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0315","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1086\/520977","article-title":"Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study","volume":"45","author":"Pe\u00f1aranda","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0320","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/319218","article-title":"Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination","volume":"32","author":"Dworkin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0325","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.vaccine.2013.10.024","article-title":"Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions","volume":"31","author":"Cho","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.069_b0330","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.069_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic vaccination response after SOTation: a systematic review","volume":"8","author":"Eckerle","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.08.069_b0340","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ki.2012.106","article-title":"Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination","volume":"82","author":"Mulley","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2018.08.069_b0345","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0891-5520(05)70279-8","article-title":"Vaccines for transplant recipients","volume":"15","author":"Molrine","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2018.08.069_b0350","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/01.inf.0000143640.03214.18","article-title":"Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants","volume":"23","author":"Nurkka","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.08.069_b0355","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/378744","volume":"37","author":"Kilpi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0360","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.vaccine.2003.03.001","article-title":"Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine","volume":"22","author":"Huebner","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.069_b0365","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/infdis\/173.1.256","article-title":"Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease","volume":"173","author":"Chan","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0370","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/315307","article-title":"Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease","volume":"181","author":"Vernacchio","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0375","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0b013e3282887e91","article-title":"Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults","volume":"21","author":"Lesprit","year":"2007","journal-title":"Aids"},{"key":"10.1016\/j.vaccine.2018.08.069_b0380","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/606046","article-title":"The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50\u201380 years","volume":"49","author":"Goldblatt","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0385","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/CVI.00721-15","article-title":"Pneumococcal vaccination in high-risk individuals: are we doing it right?","volume":"23","author":"Papadatou","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.08.069_b0390","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults","volume":"201","author":"Musher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.069_b0400","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/TP.0b013e3181ca56f8","article-title":"Effects of influenza immunization on humoral and cellular alloreactivity in humans","volume":"89","author":"Danziger-Isakov","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2018.08.069_b0405","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.transproceed.2015.12.004","article-title":"Pneumococcal 13-valent conjugate vaccine (Prevnar 13)-associated immune thrombocytopenic purpura in a renal transplant recipient: a case report","volume":"48","author":"Gupta","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.vaccine.2018.08.069_b0410","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.humimm.2013.07.010","article-title":"Vaccination against Streptococcus pneumoniae does not induce antibodies against HLA or MICA in clinically stable kidney transplant recipients","volume":"74","author":"Lindemann","year":"2013","journal-title":"Hum Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.08.069_b0415","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.healun.2018.03.001","article-title":"Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis","volume":"37","author":"Mulley","year":"2018","journal-title":"J Heart Lung Transplant"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1831209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1831209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:18Z","timestamp":1759400898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1831209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":82,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X1831209X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}